Trials / Completed
CompletedNCT02254629
The Effects of Laxative-probiotic Sequential Treatment in the Irritable Bowel Syndrome Patients
The Effects of Laxative-probiotic Sequential Treatment on the Symptoms and Fecal Microbiota in the IBS Patients.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 56 (actual)
- Sponsor
- Shandong University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
the laxative-probiotic sequential treatment might reduce the symptoms of IBS and alter the fecal microbiota of the patients in a more robust manner .
Detailed description
Probiotics can regulate intestinal immunity, repair mucosal barrier, and reportedly exert therapeutic effects on IBS patients. The laxatives could also alter the gut microflora significantly, thus the laxative-probiotic sequential treatment might affect the symptoms and the composition of fecal microbiota in the IBS patients in a more robust manner .
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Probiotic Clostridium Butyricum | probiotic:2 tablets/ times, 3 times / day for 2 weeks |
| DRUG | Laxative Polyethylene Glycol | laxative:2000 ml. |
Timeline
- Start date
- 2014-07-01
- Primary completion
- 2015-08-01
- Completion
- 2016-07-01
- First posted
- 2014-10-02
- Last updated
- 2016-08-31
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02254629. Inclusion in this directory is not an endorsement.